Data Availability
Enclosed is a manuscript entitled Treatment Outcomes for Adult Patients with Localized Osteosarcoma Treated with Chemotherapy without Methotrexate to be considered for publication in Esmo Open. Osteosarcoma is a rare disease in adults, and is the most common primary bone malignancy in children and young adolescents. Most patients present localized disease and cure rates are around 60% in the pediatric population with contemporary treatments regimens These results were established by several landmark studies during 1970s and 1980s. They demonstrated the efficacy of adjuvant chemotherapy and later neoadjuvant chemotherapy. Considering this, standard chemotherapy for adult patients frequently does not include high-dose methotrexate. A comprehension of the outcomes of these patients without methotrexate is important to understand the disease scenario of this selected population and to guide the development of new treatment strategies with acceptable tolerance. The present study aimed to evaluate the outcomes of adult patients with high-grade localized osteosarcoma treated with chemotherapy regimens without methotrexate. Due to the clinical importance of the subject, we believe that our work would be of interest for ESMO Open readers. With the submission of this letter I would like to undertake that the above-mentioned manuscript has not been published, accepted for publication and neither is under editorial review for publication elsewhere. All authors contributed to conception, drafting the article and final approval of the version being submitted. Sincerely, The authors. Corresponding author : Veridiana Pires de Camargo, MD Instituto do Cancer do Estado de Sao Paulo